Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MMG spins out vaccine company

Medical Marketing (LSE:MMG) spun out Genvax (Cambridge, U.K.), a DNA vaccine

Read the full 119 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE